146 related articles for article (PubMed ID: 38871633)
1. Targeting inflammasome complexes as a novel therapeutic strategy for mood disorders.
de Miranda AS; de Brito Toscano EC; O'Connor JC; Teixeira AL
Expert Opin Ther Targets; 2024 May; 28(5):401-418. PubMed ID: 38871633
[TBL] [Abstract][Full Text] [Related]
2. Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor.
Iwata M; Ota KT; Li XY; Sakaue F; Li N; Dutheil S; Banasr M; Duric V; Yamanashi T; Kaneko K; Rasmussen K; Glasebrook A; Koester A; Song D; Jones KA; Zorn S; Smagin G; Duman RS
Biol Psychiatry; 2016 Jul; 80(1):12-22. PubMed ID: 26831917
[TBL] [Abstract][Full Text] [Related]
3. The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers.
Gouravani M; Khalili N; Razi S; Keshavarz-Fathi M; Khalili N; Rezaei N
Expert Rev Clin Immunol; 2020 Feb; 16(2):175-187. PubMed ID: 31928260
[No Abstract] [Full Text] [Related]
4. NLRP3 Inflammasome: From Pathophysiology to Therapeutic Target in Major Depressive Disorder.
Kouba BR; Gil-Mohapel J; S Rodrigues AL
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613574
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
6. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 inflammasome-driven pathways in depression: Clinical and preclinical findings.
Kaufmann FN; Costa AP; Ghisleni G; Diaz AP; Rodrigues ALS; Peluffo H; Kaster MP
Brain Behav Immun; 2017 Aug; 64():367-383. PubMed ID: 28263786
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders.
Bhattacharya A; Jones DNC
Psychoneuroendocrinology; 2018 Dec; 98():95-100. PubMed ID: 30121550
[TBL] [Abstract][Full Text] [Related]
9. Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-κB and NLRP3 inflammasome activation.
Lee AH; Shin HY; Park JH; Koo SY; Kim SM; Yang SH
Sci Rep; 2021 Jan; 11(1):543. PubMed ID: 33436909
[TBL] [Abstract][Full Text] [Related]
10. α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β
Ebrahimi T; Rust M; Kaiser SN; Slowik A; Beyer C; Koczulla AR; Schulz JB; Habib P; Bach JP
J Neuroinflammation; 2018 Sep; 15(1):282. PubMed ID: 30261895
[TBL] [Abstract][Full Text] [Related]
11. Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder.
Alcocer-Gómez E; Casas-Barquero N; Williams MR; Romero-Guillena SL; Cañadas-Lozano D; Bullón P; Sánchez-Alcazar JA; Navarro-Pando JM; Cordero MD
Pharmacol Res; 2017 Jul; 121():114-121. PubMed ID: 28465217
[TBL] [Abstract][Full Text] [Related]
12. Blockage of P2X7 attenuates acute lung injury in mice by inhibiting NLRP3 inflammasome.
Wang S; Zhao J; Wang H; Liang Y; Yang N; Huang Y
Int Immunopharmacol; 2015 Jul; 27(1):38-45. PubMed ID: 25937482
[TBL] [Abstract][Full Text] [Related]
13. P2X7 receptor and NLRP3 inflammasome activation in head and neck cancer.
Bae JY; Lee SW; Shin YH; Lee JH; Jahng JW; Park K
Oncotarget; 2017 Jul; 8(30):48972-48982. PubMed ID: 28430665
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 inflammasome activation mediates estrogen deficiency-induced depression- and anxiety-like behavior and hippocampal inflammation in mice.
Xu Y; Sheng H; Bao Q; Wang Y; Lu J; Ni X
Brain Behav Immun; 2016 Aug; 56():175-86. PubMed ID: 26928197
[TBL] [Abstract][Full Text] [Related]
15. P2X
Yin J; Wang Y; Hu H; Li X; Xue M; Cheng W; Wang Y; Li X; Yang N; Shi Y; Yan S
J Cell Mol Med; 2017 Nov; 21(11):2695-2710. PubMed ID: 28470940
[TBL] [Abstract][Full Text] [Related]
16. Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy.
Nalbandian A; Khan AA; Srivastava R; Llewellyn KJ; Tan B; Shukr N; Fazli Y; Kimonis VE; BenMohamed L
Inflammation; 2017 Feb; 40(1):21-41. PubMed ID: 27730320
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 Ubiquitination-A New Approach to Target NLRP3 Inflammasome Activation.
Akther M; Haque ME; Park J; Kang TB; Lee KH
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445484
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy.
Higashimori A; Watanabe T; Nadatani Y; Takeda S; Otani K; Tanigawa T; Yamagami H; Shiba M; Tominaga K; Fujiwara Y; Arakawa T
Mucosal Immunol; 2016 May; 9(3):659-68. PubMed ID: 26349656
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of β-arrestin2 and NLRP3.
Zhu J; Hu Z; Han X; Wang D; Jiang Q; Ding J; Xiao M; Wang C; Lu M; Hu G
Cell Death Differ; 2018 Nov; 25(11):2037-2049. PubMed ID: 29786071
[TBL] [Abstract][Full Text] [Related]
20. Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway.
Arioz BI; Tastan B; Tarakcioglu E; Tufekci KU; Olcum M; Ersoy N; Bagriyanik A; Genc K; Genc S
Front Immunol; 2019; 10():1511. PubMed ID: 31327964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
